Get the Stockscreener App
4.75
3.85%
-0.19
Verrica Pharmaceuticals Inc stock is traded at $4.75, with a volume of 17,412.
It is down -3.85% in the last 24 hours and down -30.35% over the past month.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
See More
Previous Close:
$4.94
Open:
$4.98
24h Volume:
17,412
Relative Volume:
0.33
Market Cap:
$44.87M
Revenue:
$5.12M
Net Income/Loss:
$-67.00M
P/E Ratio:
-3.2313
EPS:
-1.47
Net Cash Flow:
$-38.94M
1W Performance:
-6.95%
1M Performance:
-30.35%
6M Performance:
-20.73%
1Y Performance:
-75.52%
1-Day Range:
$4.74
$4.98
1-Week Range:
$4.74
$5.2035
52-Week Range:
$3.816
$20.60
Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile
Name
Verrica Pharmaceuticals Inc
Sector
Industry
Phone
484-453-3300
Address
10 NORTH HIGH STREET, WEST CHESTER, PA
Compare VRCA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRCA
Verrica Pharmaceuticals Inc
|
4.75 | 47.70M | 5.12M | -67.00M | -38.94M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-06-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-05-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-25-23 | Upgrade | Needham | Hold → Buy |
| Mar-22-23 | Initiated | Jefferies | Buy |
| Feb-13-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-14-21 | Initiated | RBC Capital Mkts | Outperform |
| Dec-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-15-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-30-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-24-20 | Initiated | Northland Capital | Outperform |
| Mar-24-20 | Initiated | Needham | Buy |
| Feb-21-19 | Initiated | H.C. Wainwright | Buy |
View All
Verrica Pharmaceuticals Inc Stock (VRCA) Latest News
Verrica Pharmaceuticals Inc. stock trend forecastQuarterly Trade Review & Risk Adjusted Buy/Sell Alerts - Newser
Does Verrica Pharmaceuticals Inc. show high probability of reboundWeekly Trend Summary & Target Return Focused Picks - Newser
Developing predictive dashboards with Verrica Pharmaceuticals Inc. dataJobs Report & Verified Chart Pattern Signals - Newser
When is the best time to exit Verrica Pharmaceuticals Inc.July 2025 Big Picture & Free Long-Term Investment Growth Plans - Newser
How moving averages guide Verrica Pharmaceuticals Inc. tradingShare Buyback & High Accuracy Trade Alerts - Newser
Using Python tools to backtest Verrica Pharmaceuticals Inc. strategies - Newser
Is Verrica Pharmaceuticals Inc. a candidate for recovery playTrade Analysis Report & Verified Swing Trading Watchlists - Newser
What candlestick patterns are forming on Verrica Pharmaceuticals Inc.Trade Risk Report & Free Technical Pattern Based Buy Signals - Newser
Using Bollinger Bands to evaluate Verrica Pharmaceuticals Inc.Weekly Gains Report & Growth Focused Entry Point Reports - Newser
Best data tools to analyze Verrica Pharmaceuticals Inc. stockJuly 2025 Movers & Smart Allocation Stock Reports - Newser
Backtesting results for Verrica Pharmaceuticals Inc. trading strategiesM&A Rumor & Weekly High Conviction Ideas - Newser
Custom strategy builders for tracking Verrica Pharmaceuticals Inc.Stop Loss & Stock Portfolio Risk Control - Newser
Can technical indicators confirm Verrica Pharmaceuticals Inc.’s reversalQuarterly Profit Report & AI Forecasted Entry and Exit Points - Newser
Trend analysis for Verrica Pharmaceuticals Inc. this weekEarnings Recap Report & Weekly High Conviction Ideas - Newser
Long term hold vs stop loss in Verrica Pharmaceuticals Inc.July 2025 Highlights & Capital Protection Trade Alerts - Newser
Detecting price anomalies in Verrica Pharmaceuticals Inc. with AIAnalyst Downgrade & Stepwise Entry and Exit Trade Signals - Newser
Can swing trading help recover from Verrica Pharmaceuticals Inc. lossesWeekly Stock Recap & Long-Term Growth Plans - Newser
How hedge fund analytics apply to Verrica Pharmaceuticals Inc. stockJuly 2025 News Drivers & Proven Capital Preservation Tips - Newser
What earnings revisions data tells us about Verrica Pharmaceuticals Inc.July 2025 Analyst Calls & Low Volatility Stock Suggestions - Newser
Order flow analysis tools used on Verrica Pharmaceuticals Inc.2025 Price Targets & Expert Curated Trade Setup Alerts - Newser
Chart based exit strategy for Verrica Pharmaceuticals Inc.Market Movement Recap & Technical Entry and Exit Tips - Newser
Verrica Pharmaceuticals Inc. stock chart pattern explained2025 Pullback Review & AI Driven Stock Reports - Newser
How to monitor Verrica Pharmaceuticals Inc. with trend dashboards2025 Top Decliners & AI Driven Price Predictions - Newser
Chart based analysis of Verrica Pharmaceuticals Inc. trendsIPO Watch & Low Risk Investment Opportunities - Newser
Real time social sentiment graph for Verrica Pharmaceuticals Inc.Trade Ideas & Low Risk Investment Opportunities - Newser
What does recent volatility data suggest for Verrica Pharmaceuticals Inc.2025 Dividend Review & Growth-Oriented Investment Plans - Newser
Real time scanner hits for Verrica Pharmaceuticals Inc. explainedWeekly Gains Summary & Daily Chart Pattern Signals - Newser
How to integrate Verrica Pharmaceuticals Inc. into portfolio analysis toolsBond Market & Accurate Buy Signal Alerts - Newser
Verrica Pharmaceuticals CEO to Present at H.C. Wainwright Global Investment Conference - MSN
Published on: 2025-09-09 01:22:23 - beatles.ru
Published on: 2025-09-08 15:15:08 - beatles.ru
RSI and MACD Indicate Shift in Verrica Pharmaceuticals Inc. SentimentJuly 2025 Selloffs & Community Verified Watchlist Alerts - beatles.ru
Market reaction to Verrica Pharmaceuticals Inc.’s recent newsMarket Performance Recap & Low Risk Growth Stock Ideas - Newser
Armistice Capital LLC Sells 353,600 Shares of Verrica Pharmaceuticals Inc. $VRCA - MarketBeat
Is Verrica Pharmaceuticals Inc. still a buy after recent gainsProduct Launch & Technical Pattern Alert System - خودرو بانک
Heatmap analysis for Verrica Pharmaceuticals Inc. and competitorsProfit Target & Accurate Intraday Trading Signals - Newser
Will Verrica Pharmaceuticals Inc. rebound enough to break evenJuly 2025 Action & Expert Curated Trade Setups - Newser
Will Verrica Pharmaceuticals Inc. face regulatory challengesMarket Rally & AI Driven Stock Movement Reports - خودرو بانک
Verrica Pharmaceuticals Inc.’s volatility index tracking explainedMarket Activity Recap & Proven Capital Preservation Tips - Newser
Is Verrica Pharmaceuticals Inc. currently under institutional pressure2025 Winners & Losers & High Conviction Buy Zone Alerts - خودرو بانک
What’s the outlook for Verrica Pharmaceuticals Inc.’s sectorWeekly Gains Summary & Verified Momentum Stock Alerts - خودرو بانک
Statistical indicators supporting Verrica Pharmaceuticals Inc.’s strengthMarket Risk Report & Reliable Price Breakout Signals - Newser
Top chart patterns to watch in Verrica Pharmaceuticals Inc.2025 Technical Patterns & Low Drawdown Investment Ideas - Newser
Will Verrica Pharmaceuticals Inc. benefit from macro trendsMarket Activity Recap & Real-Time Volume Analysis - Newser
Verrica Pharmaceuticals Inc Stock (VRCA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):